Tolerance and Acceptability Evaluation AYMES Cardiff
NCT04703894 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2021-01-11
Summary
To evaluate tolerance and acceptability of 'CARDIFF' in patients requiring supplementary oral nutritional support compared with currently available alternatives.
Conditions
- Malnutrition
Interventions
- DIETARY_SUPPLEMENT
-
AYMES 'CARDIFF'
AYMES CARDIFF is a Food for Special Medical Purposes (FSMP) and must, therefore, be used under medical supervision. It is not designed as a sole source of nutrition.
Sponsors & Collaborators
-
Aymes International Limited
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-06
- Primary Completion
- 2020-01-13
- Completion
- 2020-01-13
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
NCT00362856 ·Status: COMPLETED ·Phase: PHASE2
-
The Bioavailability of Mycoprotein
NCT04233411 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Larazotide Acetate to Treat Celiac Disease.
NCT00386165 ·Status: COMPLETED ·Phase: PHASE1
-
Gluten Sensibility in Elite Athletes
NCT03101410 ·Status: COMPLETED ·Phase: NA
-
Coverage of Requirements After Consumption of a Nutritional Formula in Patients With Chewing/Swallowing Problems.
NCT03727191 ·Status: COMPLETED ·Phase: NA
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
NCT05353985 ·Status: COMPLETED ·Phase: PHASE2
-
Diet and Behavior in Young Children With Autism
NCT00090428 ·Status: COMPLETED ·Phase: PHASE1
-
Gluten Sensitivity in Non-Celiac Patients
NCT01485341 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
NCT04530123 ·Status: COMPLETED ·Phase: PHASE2
-
In Vivo Effects of the Gluten Friendly Bread in Coeliac Disease
NCT03168490 ·Status: TERMINATED ·Phase: NA
-
GlutDigest - Pilot Study
NCT04489836 ·Status: COMPLETED ·Phase: NA
-
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
NCT01396213 ·Status: COMPLETED ·Phase: PHASE2
-
Healthcare Decisions on Dietary and Environmental Allergen Exposure
NCT03144908 ·Status: UNKNOWN
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy
NCT03352193 ·Status: RECRUITING
-
Tolerance of Cereals for Atopic Children
NCT01029184 ·Status: TERMINATED ·Phase: NA
-
Amount of Lactose Causing Symptoms in Lactose Intolerant People
NCT00395954 ·Status: COMPLETED
-
Non Celiac Gluten Sensitivity, DBPCFC in Adolescents
NCT04639921 ·Status: UNKNOWN ·Phase: NA
-
Study of Tolerance to Oral Peanut
NCT01259804 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
NCT00889473 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of KAN-101 in Celiac Disease (ACeD)
NCT04248855 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Study of CCX282-B in Patients With Celiac Disease
NCT00540657 ·Status: COMPLETED ·Phase: PHASE2
-
"Gluten Friendly" Treatment in Celiac Disease
NCT03137862 ·Status: COMPLETED ·Phase: NA
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA